2002, Number 2
Next >>
Gac Med Mex 2002; 138 (2)
Myocardial Revascularization vs. Percutaneous Transluminal Coronary Angioplasty for Treatment of Ischemic Cardiopathy.
Careaga-Reyna G, Salazar-Garrido D, Argüero-Sánchez R
Language: Spanish
References: 12
Page: 133-138
PDF size: 44.93 Kb.
ABSTRACT
Background and objective: ischemic heart disease affects a high number of patients, and may be treated by surgery or coronary angioplasty. The objective of this study is to compare the middle term results of both procedures.
Material and methods: Between January and March of 1999, 59 patients with a mean age of 65 years old ranging 46 to 79, were treated with myocardial revascularization (group I) and 57 patients with a mean age of 59 years old ranging 33 to 88 were submitted to coronary angioplasty (group II). It was evaluated and compared risk factors, morbidity, mortality, evolution in two years after the procedures, presence of symptoms, freedom of events.
Results: In group I a higher number of diabetic patients was found. The 89.8% of patients was asymptomatic two years after the procedure in group I against 52.6% in group II (p=0.03). One patient in group I presented angina six months after the procedure and 27 patients in group II (47.3%), presented angina between the first seven months after the procedure (p =0.034). Morbidity affects in special to diabetic patients and was higher in group I. Mortality was similar in both groups: 6.7% for group I and 6% in group II. The length of stay in hospital was lower in group II (p = 0.03).
Conclusion: In a middle time, coronary artery bypass grafting offers better results related to freedom of angina and better quality of life,
REFERENCES
1. Kirklin J-Barrat-Boyes B. Cardiac surgery 2nd ed. Vol 1. USA: Churchill Livingstone 1993. p. 286-370.
2. Eagle KA, Guyton RA, Davidoff R, Ewy GA, Fonger J, Gardner TI, et al. ACC/AHA Guidelines for coronary artery bypass graft surgery: executive summary and recommen-dations. Circulation 1999;100:1464-1480.
3. Ryan Guadalajara JF. Cardiología 4th ed. México: Ed. Méndez Cervantes. 1991. p. 827-961.
4. Ryan TI, Bauman WB, Kennedy JW, Kereiakes DI, King SB III, McCallister BD, et al. Guidelines for percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1993;22: 2033-2054.
5. Sato T, Isomura T, Suma H, Horji T. Coronary artery bypass with gastroepiploic artery composite graft. Ann Thorac Surg 2000;69:65-9.
6. Antman EM, Fox KM. Guidelines for the diagnosis and management of unstable angina and non-Q-wave myocardial infarction: proposed revisions. Am Heart J 2000;139:461-475.
7. Crundy S, Pasternah R, Greenland P, Smith S, et al. Assessment of cardiovascular risk by use of multiple risk-factor assessment equations. Circulation 1999;100:1481-92.
8. Ryan TI, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, et al. 1999 update: ACC/AHA Guidelines for the management of patients with acute myocardial infarction executive summary and recommendations. Circulation 1999;100:1016-1030.
9. Mikleborough L, Carson S, Tamariz M, Ivanov J. Results of revascularization in patients with severe left ventricular dysfunction. J Thorac Cardiovasc Surg 2000;19:50-7.
Veldkamp RF, Valk SDA, van Domburg RT, van Herwerden LA, Mecter K. Mortality and repeat interventions up until 20 years after aorto-coronary bypass surgery with saphenous vein grafts. Eur Heart J 2000;21:747-753.
Careaga G, Santaella M, Esparza J, Argüero R. Revascularización miocárdica sin circulación extracor pórea. Cir Ciruj 1998;66:85-88.
Arom KV, Flavin TF, Emery RW, Kshettry VR, Janey PA, Petersen RJ. Safety and efficacy of off-pump coronary artery bypass grafting. Ann Thorac Surg 2000;69:704-710.